Gelesis Holdings, Inc. (GLSHQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jun 13, 2025
Gelesis Holdings Revenue
Gelesis Holdings had revenue of $1.11M in the quarter ending June 30, 2023, a decrease of -87.66%. This brings the company's revenue in the last twelve months to $12.14M, down -45.79% year-over-year. In the year 2022, Gelesis Holdings had annual revenue of $25.77M with 130.37% growth.
Revenue (ttm)
12.14M
Revenue Growth
-45.79%
P/S Ratio
0.00
Revenue / Employee
130.54K
Employees
93
Market Cap
73.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 25.77M | 14.58M | 130.37% |
Dec 31, 2021 | 11.19M | -10.26M | -47.84% |
Dec 31, 2020 | 21.44M | - | - |
Dec 31, 2019 | - | - | - |
Dec 31, 2014 | 209.00K | -5.30M | -96.20% |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |